19 June 2013
Keywords: UK. NICE, Skin cancer, Roche, Zelboraf, Bristol-Myers, Yervoy
Article | 01 November 2012
The UK’s drugs watchdog the National Institute for Health and Clinical Excellence (NICE) this morning (November 2) issued ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 November 2012
18 June 2013
© 2013 thepharmaletter.com